← All articles

The Migraine That Wasn't: When a Spinal CSF Leak Is Hiding in Plain Sight

Worse standing. Better lying down. Years of "treatment-resistant migraine." Spontaneous intracranial hypotension is the diagnosis that takes an average of 13 months — and the one you need to rule out before accepting "chronic."

By Rustam Iuldashov
30 years living with migraine · Founder, Migraine Companion
📅 Published May 21, 2026 · ⏱ 6 min read · 🔬 28 peer-reviewed sources · 🔄 Last reviewed May 21, 2026
Educational content. Not medical advice. Always consult a qualified healthcare professional about persistent or treatment-resistant headaches.

Most migraine guides teach you what migraine is. This one is about what it sometimes isn't.

Each year, three to five people per 100,000 develop spontaneous intracranial hypotension, or SIH[1, 2]. The numbers look small. The misdiagnosis rate does not. In the most cited study on the subject, 94% of SIH patients were initially given the wrong diagnosis, and the average delay to the correct one was 13 months — with some cases stretching to 13 years[3]. The most common wrong label was migraine.

SIH is not migraine. It is a plumbing problem. Somewhere along the spine, a tiny hole in the dura — the tough membrane that holds your cerebrospinal fluid (CSF) in — has opened. Fluid leaks out. The brain, which normally floats in about 150 ml of CSF, loses some of its cushion and starts to sag, tugging on the pain-sensitive structures it's anchored to[4]. The result is a headache that looks like migraine, sounds like migraine, and responds to migraine drugs the way a flat tire responds to a fuel additive.

If you've been told you have "treatment-resistant" or "chronic daily" migraine, this is the diagnosis worth ruling out before accepting that label.

The signature you can feel for yourself

The classic fingerprint of SIH fits in one sentence: the headache is worse upright and dramatically better lying down[5, 6]. In the acute phase, the change can happen within fifteen minutes either way. Patients often remember the exact moment it began — mid-cough, mid-stretch, mid-workout[4].

This is physics, not pharmacology. When you stand, gravity pulls fluid down the spine and away from the skull. When you lie flat, pressure equalizes and the brain refloats. Migraine pain may worsen with activity, but it does not reliably vanish within fifteen minutes of going horizontal[7].

The orthostatic window narrows over time

In a prospective study, 93% of patients presenting within ten weeks of onset had textbook orthostatic headaches. Past ten weeks, fewer than 63% still did[8]. A 2024 review of 90 SIH patients found that 24% had no positional component at all, and 1% had no headache whatsoever[9].

So the longer SIH is missed, the less it looks like itself. The leak keeps going. The headache becomes constant. The patient gets relabeled as "chronic migraine."

⚠️ When to seek urgent medical care

Untreated SIH can occasionally progress to serious complications including subdural hematoma, cerebral venous thrombosis, and rarely, brain herniation. Seek emergency care immediately if you experience any of the following:

  • Sudden, severe "thunderclap" headache unlike anything before
  • Progressive drowsiness, confusion, slurred speech, or difficulty staying awake
  • New weakness, numbness, or loss of coordination on one side of the body
  • Sudden visual changes, double vision, or loss of vision
  • Seizures
  • Fever, neck stiffness, and headache together (rule out meningitis)

These symptoms warrant immediate evaluation, not a wait-and-see approach.

Why it mimics migraine so well

SIH borrows almost the entire migraine symptom list. Nausea, vomiting, photophobia, phonophobia, neck stiffness, dizziness — each appears in 28–54% of SIH patients[10]. A meta-analysis of more than 2,000 cases found headache in 97%, usually occipital, frontal, or diffuse, often with the same autonomic features as a severe migraine attack[10].

A 2024 prospective study from a tertiary headache clinic measured the overlap directly: 75% of patients with confirmed SIH also reported at least one classic migraine symptom, phonophobia being the most common at 62.5%[11]. The presence of migrainous features did not predict whether a patient actually had a leak. In other words, a person can look fully migrainous and still have a hole in their dura.

Quieter clues point away from migraine. Three matter most:

Cochleovestibular symptoms

Tinnitus, muffled hearing, a feeling of fullness in the ears, or true vertigo — reported in 27–28% of SIH patients[10]. Low CSF pressure alters inner-ear fluid dynamics. Episodic migraine rarely produces persistent tinnitus.

Neck and interscapular pain

Forty-three percent of SIH patients report neck pain or stiffness as a major feature — often more bothersome than the headache itself[10]. Pain between the shoulder blades is a particular red flag: it points to a thoracic-level leak.

The "second half of the day" pattern

Some chronic SIH patients no longer feel an immediate positional change, but report headaches that reliably build through the afternoon and evening — worse the longer they've been upright[12]. It looks like a tension headache. It isn't.

What goes wrong inside the skull

Anatomical cross-section showing the mechanism of spontaneous intracranial hypotension: brain sag at the top with pachymeningeal enhancement along the dura, and a small CSF leak at the thoracic level of the spine, with fluid escaping into the epidural space.
The mechanism of SIH. A small dural tear in the spine leaks CSF, the brain loses its cushion and sags downward, and the dura becomes engorged and enhanced on contrast MRI — the radiologic signature called pachymeningeal enhancement.

The mechanism is elegant and unforgiving. The Monro-Kellie hypothesis says the skull is a closed box containing brain, blood, and CSF, and that the total volume must stay constant[4]. When CSF leaks out, something has to expand to take its place. What expands is blood: the dural veins engorge, the pituitary swells, and small subdural fluid collections may form. On contrast-enhanced brain MRI, this appears as diffuse, smooth thickening and brightening of the dura — pachymeningeal enhancement[13].

SEEPS — the radiologist's mnemonic

Subdural collections · Enhancement of the pachymeninges · Engorgement of venous structures · Pituitary hyperemia · Sagging of the brain[14]. Five findings that, together, are the visual signature of low CSF volume on MRI.

In a series of 99 SIH cases, pachymeningeal enhancement was visible on MRI in 83%, and brain sag in 61%[15]. And yet brain MRI is normal in roughly 19% of SIH cases overall — and the longer the leak has been running, the cleaner the imaging tends to look[10, 16]. A normal MRI is not the all-clear it sounds like.

The same holds for lumbar puncture. The textbook says SIH should show a CSF pressure under 60 mm of water. Reality: only about 34% of SIH patients have a pressure that low when measured[17]. The other two-thirds have normal pressure with a real, treatable leak. Diagnostic criteria that demand low pressure or positive imaging will miss the majority of patients[11].

A patient sits in a neurologist's office looking at a wall-mounted MRI display. The neurologist points to a bright ring of pachymeningeal enhancement along the inside of the skull — the diagnostic signature of spontaneous intracranial hypotension that took months to find.
The moment a chronic headache finally has a name. The bright ring outlining the brain on the MRI — pachymeningeal enhancement — is the finding that distinguishes SIH from years of "treatment-resistant migraine."

What actually treats it

Migraine medication does almost nothing for SIH. That alone is reason enough to revisit any "treatment-resistant migraine" diagnosis. The treatment is to seal the hole.

Conservative care — strict bed rest, hydration, and caffeine — helps about 28% of cases, and the relief is often temporary[18]. First-line definitive treatment is the epidural blood patch (EBP): 15–20 ml of the patient's own blood is injected into the epidural space, where it clots and seals the leak. A meta-analysis of 500 patients found that 60% achieved complete remission within 48 hours of the first patch[19]. Patients who don't respond often improve after a second or third patch, or after a targeted patch directed at an imaging-confirmed leak site[20].

For the small subset who fail repeated patches, surgical closure of the dural defect or ligation of a CSF-venous fistula — a leak type only identified in 2014 — produces durable resolution[21, 22].

The question to ask

If you've been treated for migraine more than six months and aren't improving

One question changes the conversation: "Is my headache reliably worse when I'm upright and better when I'm flat?"

If yes, ask your doctor about SIH. Ask whether a brain MRI with contrast is warranted to look for pachymeningeal enhancement and brain sag. Ask whether, in the absence of clear imaging findings but with a convincing orthostatic history, an empiric epidural blood patch is reasonable — a 2024 prospective study found that 74% of patients who benefited from EBPs did not meet formal ICHD-3 criteria for SIH[11].

SIH is rare. The cost of missing it is not.

Key Takeaways

  • 94% of SIH patients are initially misdiagnosed, most often as migraine, and the average delay to the correct diagnosis is 13 months[3].
  • The hallmark is positional: headache worse standing or sitting, better lying flat. In the first ten weeks, this pattern is present in 93% of cases[8].
  • Migraine medication does not work because SIH is structural, not neurochemical. The cause is a small dural leak losing cerebrospinal fluid.
  • Red flags beyond positionality: persistent tinnitus or muffled hearing, neck and interscapular pain, and "second half of the day" headaches that worsen the longer you're upright[10, 12].
  • A normal MRI or normal lumbar puncture does not rule out SIH — imaging is normal in ~19% of cases, and CSF pressure is normal in ~66%[10, 17].
  • Treatment is the epidural blood patch, which produces complete remission in roughly 60% of cases after the first patch[19].
  • Ask your doctor the orthostatic question if you have been labeled "chronic" or "treatment-resistant" migraine for more than six months.

⚕️ Medical Disclaimer

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The information presented here reflects the current peer-reviewed scientific literature on spontaneous intracranial hypotension as of May 2026, but it does not constitute a clinical recommendation for any individual.

If you are experiencing chronic, treatment-resistant headaches — particularly with a positional component — please consult a neurologist or headache specialist. Spontaneous intracranial hypotension requires diagnostic imaging, clinical evaluation, and procedural treatment that can only be safely delivered by qualified medical professionals. Do not attempt to self-diagnose based on this article, and do not stop or change any prescribed migraine treatment without speaking to your doctor first. Epidural blood patches and related procedures carry their own risks and must be performed in appropriate medical settings.

If you experience any of the emergency symptoms listed earlier in this article — thunderclap headache, progressive drowsiness, slurred speech, new weakness, sudden visual changes, seizures, or fever with neck stiffness — seek immediate medical care.

References

  1. Schievink WI. “Spontaneous intracranial hypotension.” N Engl J Med 385(23):2173–2178 (2021). doi:10.1056/NEJMra2101561. Study design: Narrative review.
  2. Schievink WI, Maya MM, Moser FG, et al. “Incidence of spontaneous intracranial hypotension in a community: Beverly Hills, California, 2006–2020.” Cephalalgia 42(4–5):312–316 (2022). doi:10.1177/03331024211048510. Study design: Epidemiologic cohort. n=53.
  3. Schievink WI. “Misdiagnosis of spontaneous intracranial hypotension.” Arch Neurol 60(12):1713–1718 (2003). doi:10.1001/archneur.60.12.1713. Study design: Consecutive case series. n=18.
  4. Mokri B. “The Monro-Kellie hypothesis: applications in CSF volume depletion.” Neurology 56(12):1746–1748 (2001). doi:10.1212/wnl.56.12.1746. Study design: Review.
  5. Headache Classification Committee of the International Headache Society. “The International Classification of Headache Disorders, 3rd edition (ICHD-3): 7.2.3 Headache attributed to spontaneous intracranial hypotension.” Cephalalgia 38(1):1–211 (2018). doi:10.1177/0333102417738202. Study design: Consensus criteria.
  6. Schievink WI, Maya MM, Louy C, Moser FG, Tourje J. “Diagnostic criteria for spontaneous spinal CSF leaks and intracranial hypotension.” AJNR Am J Neuroradiol 29(5):853–856 (2008). doi:10.3174/ajnr.A0956. Study design: Diagnostic criteria validation. n=107.
  7. Lin J, Zhang S, He F, Liu M, Ma X. “Spontaneous intracranial hypotension: a commonly missed cause of secondary headache.” Cureus 17(11):e97070 (2025). doi:10.7759/cureus.97070. Study design: Case report and review.
  8. Häni L, Fung C, Jesse CM, Ulrich CT, Miesbach T, Cipriani DR, et al. “Insights into the natural history of spontaneous intracranial hypotension from infusion testing.” Neurology 95(3):e247–e255 (2020). doi:10.1212/WNL.0000000000009812. Study design: Prospective cohort. n=85.
  9. Pradeep A, Madhavan AA, Brinjikji W, Cutsforth-Gregory JK. “Diagnosis and treatment of spontaneous intracranial hypotension: pearls and pitfalls.” Neurol Clin Pract 14(3):e200290 (2024). doi:10.1212/CPJ.0000000000200290. Study design: Clinical review.
  10. D'Antona L, Jaime Merchan MA, Vassiliou A, Watkins LD, Davagnanam I, Toma AK, Matharu MS. “Clinical presentation, investigation findings, and treatment outcomes of spontaneous intracranial hypotension syndrome: a systematic review and meta-analysis.” JAMA Neurol 78(3):329–337 (2021). doi:10.1001/jamaneurol.2020.4799. Study design: Systematic review and meta-analysis. n=2,194 across 144 studies.
  11. Callen AL, Birlea M, Badesha N, Kim DK, Carrol IR, Calabrese L, et al. “Long-term epidural patching outcomes and predictors of benefit in patients with suspected CSF leak nonconforming to ICHD-3 criteria.” Neurology 102(11):e209449 (2024). doi:10.1212/WNL.0000000000209449. Study design: Prospective cohort with nested case-control. n=85.
  12. Pradeep A, Madhavan AA, Brinjikji W, et al. “Recommendations for the diagnosis and treatment of spontaneous intracranial hypotension.” Radiol Med 130(5):721–736 (2025). doi:10.1007/s11547-025-02116-6. Study design: Expert recommendations.
  13. Mokri B, Atkinson JLD, Dodick DW, Miller GM, Piepgras DG. “Absent pachymeningeal gadolinium enhancement on cranial MRI despite symptomatic CSF leak.” Neurology 52(2):450–451 (1999). doi:10.1212/WNL.52.2.450. Study design: Case series.
  14. Severance S, Daylor V, Petrucci T, Gensemer C, Patel S, Norris RA. “Hypermobile Ehlers-Danlos syndrome and spontaneous CSF leaks: the connective tissue conundrum.” Front Neurol 15:1452409 (2024). doi:10.3389/fneur.2024.1452409. Study design: Narrative review.
  15. Kranz PG, Tanpitukpongse TP, Choudhury KR, Amrhein TJ, Gray L. “Imaging signs in spontaneous intracranial hypotension: prevalence and relationship to CSF pressure.” AJNR Am J Neuroradiol 37(7):1374–1378 (2016). doi:10.3174/ajnr.A4689. Study design: Retrospective cohort. n=99.
  16. Massey TH, Robertson NP. “Spontaneous intracranial hypotension: features, diagnosis and management.” J Neurol 268(7):2675–2677 (2021). doi:10.1007/s00415-021-10500-1. Study design: Review.
  17. Kranz PG, Tanpitukpongse TP, Choudhury KR, Amrhein TJ, Gray L. “How common is normal cerebrospinal fluid pressure in spontaneous intracranial hypotension?” Cephalalgia 36(13):1209–1217 (2016). doi:10.1177/0333102415623071. Study design: Retrospective cohort. n=106.
  18. Park JH, Yoon SH. “IIH, SIH and headache: diagnosis and treatment update.” eNeurologicalSci 38:100517 (2024). doi:10.1016/j.ensci.2024.100517. Study design: Narrative review.
  19. Signorelli F, Caccavella VM, Giordano M, Ioannoni E, Caricato A, Polli FM, et al. “A systematic review and meta-analysis of factors affecting the outcome of the epidural blood patching in spontaneous intracranial hypotension.” Neurosurg Rev 44(6):3079–3085 (2021). doi:10.1007/s10143-021-01505-5. Study design: Systematic review and meta-analysis. n=500 across 6 studies.
  20. Palermo M, Sturiale CL, D'Arrigo S, Trevisi G. “Targeted versus nontargeted epidural blood patch for spontaneous intracranial hypotension: a systematic review and meta-analysis.” Eur J Neurol 32(7):e70239 (2025). doi:10.1111/ene.70239. Study design: Systematic review and meta-analysis. n=7 studies.
  21. Schievink WI, Maya MM, Jean-Pierre S, Nuño M, Prasad RS, Moser FG. “A classification system of spontaneous spinal CSF leaks.” Neurology 87(7):673–679 (2016). doi:10.1212/WNL.0000000000002986. Study design: Retrospective cohort. n=568.
  22. Wang TY, Karikari IO, Amrhein TJ, Gray L, Kranz PG. “Clinical outcomes following surgical ligation of cerebrospinal fluid-venous fistula in patients with spontaneous intracranial hypotension: a prospective case series.” Oper Neurosurg 18(3):239–245 (2020). doi:10.1093/ons/opz134. Study design: Prospective case series. n=23.
  23. Cheema S, Anderson J, Angus-Leppan H, Davagnanam I, Davies P, Galtrey CM, et al. “Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension.” J Neurol Neurosurg Psychiatry 94(10):835–843 (2023). doi:10.1136/jnnp-2023-331166. Study design: Consensus guideline.
  24. Cheema S, Anderson J, Angus-Leppan H, et al. “Survey of healthcare professionals' knowledge, attitudes and practices regarding spontaneous intracranial hypotension.” BMJ Neurol Open 4(2):e000347 (2022). doi:10.1136/bmjno-2022-000347. Study design: Cross-sectional survey. n=180 clinicians.
  25. Cheema S, Joy C, Pople J, Snape-Burns J, Trevarthen T, Matharu M. “Patient experience of diagnosis and management of spontaneous intracranial hypotension: a cross-sectional online survey.” BMJ Open 12(1):e057438 (2022). doi:10.1136/bmjopen-2021-057438. Study design: Cross-sectional survey. n=64 patients.
  26. Kapan A, Waldhör T, Wöber C. “Assessing the effects of spontaneous intracranial hypotension on quality of life, work ability and disability.” Wien Klin Wochenschr 137(7-8):198–207 (2025). doi:10.1007/s00508-024-02423-4. Study design: Cross-sectional study. n=79.
  27. Reinstein E, Pariani M, Bannykh S, Rimoin DL, Schievink WI. “Connective tissue spectrum abnormalities associated with spontaneous cerebrospinal fluid leaks: a prospective study.” Eur J Hum Genet 21(4):386–390 (2013). doi:10.1038/ejhg.2012.191. Study design: Prospective cohort. n=50.
  28. Dobrocky T, Nicholson P, Häni L, Mordasini P, Krings T, Brinjikji W, et al. “Spontaneous intracranial hypotension: searching for the CSF leak.” Lancet Neurol 21(4):369–380 (2022). doi:10.1016/S1474-4422(21)00423-3. Study design: Review.
Rustam Iuldashov, founder of Migraine Companion

Rustam Iuldashov

Founder, Migraine Companion · 30 years living with migraine

I built Migraine Companion because the gap between what the science says and what patients are actually told in the exam room is still too wide. SIH is one of the clearest examples of that gap — a treatable condition that gets called "chronic migraine" for thirteen months on average. Articles like this one exist to close the distance.

I am not a physician. All clinical claims here are sourced from peer-reviewed publications listed above. The intent is to give you and your doctor a shared starting point — not to replace the conversation.

Transparency disclosure: Migraine Companion is independent. We accept no funding from pharmaceutical manufacturers of migraine medication, from neuroradiology equipment makers, or from providers of epidural blood patch services.

📚 Editorial Standards · Sources Used in This Article

  • New England Journal of Medicine — Schievink review on SIH (2021)
  • JAMA Neurology — D'Antona meta-analysis of 2,194 SIH cases (2021)
  • Lancet Neurology — Dobrocky review on searching for the CSF leak (2022)
  • Neurology & Neurology Clinical Practice — Häni, Callen, Pradeep, Schievink (2020–2024)
  • Cephalalgia — Kranz on CSF pressure prevalence (2016); ICHD-3 criteria (2018); Schievink incidence study (2022)
  • AJNR American Journal of Neuroradiology — diagnostic criteria and imaging prevalence (2008, 2016)
  • BMJ Open & BMJ Neurology Open — Cheema patient and clinician surveys (2022)
  • J Neurol Neurosurg Psychiatry — Multidisciplinary consensus guideline (2023)
  • Eur J Neurology & Neurosurg Rev — meta-analyses on epidural blood patching (2021, 2025)

The right question, asked early

Migraine Companion is built around a simple practice: track what your body is actually doing, name the patterns honestly, and bring them to the people who can help. Sometimes the answer is migraine. Sometimes it isn't. Either way, the diary is where the conversation starts.

📅 Last reviewed: May 21, 2026 · 🔄 Next scheduled review: November 21, 2026